![IR80-274 anti VE-Cadherin / CD144 antibody WB image IR80-274 anti VE-Cadherin / CD144 antibody WB image](/Upload/Products/1685690560_4d89117d98d755618dd9.jpg)
![IR80-274 anti VE-Cadherin / CD144 antibody ICC/IF image IR80-274 anti VE-Cadherin / CD144 antibody ICC/IF image](/Upload/Products/1685690571_69adf0cb9348b27a2666.jpg)
![IR80-274 anti VE-Cadherin / CD144 antibody IHC image IR80-274 anti VE-Cadherin / CD144 antibody IHC image](/Upload/Products/1690866138_5d3fc838d71c0295a081.jpg)
![IR80-274 anti VE-Cadherin / CD144 antibody IHC image IR80-274 anti VE-Cadherin / CD144 antibody IHC image](/Upload/Products/1690862676_617814840bb133502db6.jpg)
+1
Product Includes
-
Application Dilution
Western Blot 1:1000
Immunofluorescence 1:300 – 1:500
Immunohistochemistry (Paraffin) 1:100 – 1:200
Immunofluorescence 1:300 – 1:500
Immunohistochemistry (Paraffin) 1:100 – 1:200
Storage
Long time storage is recommended at -20°C.
100mM Tris Glycine, 1% BSA, 30% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.
Gently mix before use. Optimal concentrations and conditions for each application should be determined by the user.
100mM Tris Glycine, 1% BSA, 30% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative.
Gently mix before use. Optimal concentrations and conditions for each application should be determined by the user.
Specificity / Sensitivity
Endogenous
Source / Immunogen
cadherin 5, type 2 (vascular endothelium)
This gene encodes a classical cadherin of the cadherin superfamily. The encoded preproprotein is proteolytically processed to generate the mature glycoprotein. This calcium-dependent cell-cell adhesion molecule is comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Functioning as a classical cadherin by imparting to cells the ability to adhere in a homophilic manner, this protein plays a role in endothelial adherens junction assembly and maintenance. This gene is located in a gene cluster in a region on the long arm of chromosome 16 that is involved in loss of heterozygosity events in breast and prostate cancer. [provided by RefSeq, Nov 2015]